Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
20–74
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with confirmed breast cancer who have received prior trastuzumab.
Patients must have adequate blood, liver, and kidney function and either be fully active or restricted only in performing strenuous activity.
Female patients of child-bearing potential must be willing to abstain from intercourse from 2 weeks prior to administration of the first dose of study medication until 28 days after the final dose of study medication or be willing to consistently and correctly use an acceptable method of birth control.
You may not be if
Patients with certain heart problems.
Clareo Health | GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast Cancer
